Yamazaki, Takahiro

Publications

Sort by

Co-Author Network

selected publications

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology. 2021 Academic Article GET IT
Times cited: 25
ATP and cancer immunosurveillance. The EMBO journal. 2021 Review GET IT
Times cited: 65
Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells. STAR protocols. 2021 Academic Article GET IT
Times cited: 3
Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery. Immunity. 2021 Academic Article GET IT
Times cited: 14
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. The Journal of clinical investigation. 2021 Academic Article GET IT
Times cited: 75
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER⁺ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Academic Article GET IT
Times cited: 33
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. Trends in cancer. 2021 Review GET IT
Times cited: 20
Autophagy in the cancer-immunity dialogue. Advanced drug delivery reviews. 2020 Review GET IT
Times cited: 35
Detection of immunogenic cell death and its relevance for cancer therapy. Cell death & disease. 2020 Review GET IT
Times cited: 284
MPA/DMBA-driven mammary carcinomas. Methods in cell biology. 2020 Academic Article GET IT
Times cited: 2
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications. 2020 Academic Article GET IT
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature immunology. 2020 Academic Article GET IT
Times cited: 156
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications. 2020 Academic Article GET IT
Times cited: 58
Mitochondrial control of innate immune signaling by irradiated cancer cells. Oncoimmunology. 2020 Editorial Article GET IT
Times cited: 21
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal for immunotherapy of cancer. 2020 Review GET IT
Times cited: 459
PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models. Oncoimmunology. 2020 Academic Article GET IT
Times cited: 64
Correction to: Methods to Detect Immunogenic Cell Death In Vivo. Methods in molecular biology (Clifton, N.J.). 2020 Academic Article GET IT
Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment. Cancer treatment and research. 2020 Academic Article GET IT
Times cited: 8
Methods to Detect Immunogenic Cell Death In Vivo. Methods in molecular biology (Clifton, N.J.). 2020 Academic Article GET IT
Times cited: 5
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade. Cell research. 2019 Academic Article GET IT
Times cited: 115
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 83
Detection and quantification of cytosolic DNA. Methods in enzymology. 2019 Academic Article GET IT
Times cited: 5
Extracorporeal photochemotherapy induces bona fide immunogenic cell death. Cell death & disease. 2019 Academic Article GET IT
Times cited: 40
Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature communications. 2019 Article GET IT
Times cited: 6
Monitoring abscopal responses to radiation in mice. Methods in enzymology. 2019 Academic Article GET IT
Times cited: 2
Tumor lysis with LTX-401 creates anticancer immunity. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 22
Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature communications. 2019 Academic Article GET IT
Times cited: 150
Linking cellular stress responses to systemic homeostasis. Nature reviews. Molecular cell biology. 2018 Review GET IT
Times cited: 242
The oncolytic compound LTX-401 targets the Golgi apparatus. Cell death and differentiation. 2017 Academic Article GET IT
Times cited: 2
Immune recognition of irradiated cancer cells. Immunological reviews. 2017 Review GET IT
Times cited: 61
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance. Immunological reviews. 2017 Review GET IT
Times cited: 61
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer. Oncoimmunology. 2017 Academic Article GET IT
Times cited: 22
Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 2017 Review GET IT
Times cited: 56
Blinatumomab bridges the gap between leukemia and immunity. Oncoimmunology. 2017 Editorial Article GET IT
Times cited: 4
TREX1 Cuts Down on Cancer Immunogenicity. Trends in cell biology. 2017 Article GET IT
Times cited: 16
Heavy Metal to Rock the Immune Infiltrate. Trends in immunology. 2017 Comment GET IT
Times cited: 7
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy. Cancer research. 2017 Academic Article GET IT
Times cited: 91
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. 2016 Academic Article GET IT
Times cited: 479
The oncolytic compound LTX-401 targets the Golgi apparatus. Cell death and differentiation. 2016 Academic Article GET IT
Times cited: 17
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer cell. 2016 Academic Article GET IT
Times cited: 347
Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway. Oncoimmunology. 2016 Academic Article GET IT
Times cited: 59
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors. Immunity. 2016 Review GET IT
Times cited: 666
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Oncoimmunology. 2016 Academic Article GET IT
Times cited: 10184
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity. 2016 Academic Article GET IT
Times cited: 638
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma. The Journal of clinical investigation. 2016 Academic Article GET IT
Times cited: 57
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science (New York, N.Y.). 2015 Academic Article GET IT
Times cited: 2116
Improvement of immunogenic chemotherapy by STAT3 inhibition. Oncoimmunology. 2015 Academic Article GET IT
Times cited: 64
Autocrine signaling of type 1 interferons in successful anticancer chemotherapy. Oncoimmunology. 2015 Academic Article GET IT
Times cited: 69
A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer research. 2015 Academic Article GET IT
Times cited: 165
STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells. Cancer research. 2015 Academic Article GET IT
Times cited: 67
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nature medicine. 2014 Academic Article GET IT
Times cited: 694
Why should we need the gut microbiota to respond to cancer therapies?. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 1360
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (New York, N.Y.). 2013 Academic Article GET IT
Times cited: 1334
Crosstalk between ER stress and immunogenic cell death. Cytokine & growth factor reviews. 2013 Review GET IT
Times cited: 135
Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 202
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 2013 Academic Article GET IT
Times cited: 492
An immunosurveillance mechanism controls cancer cell ploidy. Science (New York, N.Y.). 2012 Academic Article GET IT
Times cited: 315
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Science translational medicine. 2012 Academic Article GET IT
Times cited: 312
Real-time in vivo cellular imaging of graft-versus-host disease and its reaction to immunomodulatory reagents. Immunology letters. 2012 Academic Article GET IT
Times cited: 2
Harnessing γδ T cells in anticancer immunotherapy. Trends in immunology. 2012 Academic Article GET IT
Times cited: 95
Desirable cell death during anticancer chemotherapy. Annals of the New York Academy of Sciences. 2010 Review GET IT
Times cited: 60
Cytokine production by M-CSF- and GM-CSF-induced mouse bone marrow-derived macrophages upon coculturing with late apoptotic cells. Cellular immunology. 2008 Academic Article GET IT
Times cited: 17
Effects of Kupffer cell-depletion on Concanavalin A-induced hepatitis. Cellular immunology. 2008 Academic Article GET IT
Times cited: 42

more ...

less ...

Background

education and training

Ph.D., Toho University School of Medicine (Japan) 2009
M.S., Toho University School of Medicine (Japan) 2006
B.S., Toho University School of Medicine (Japan) 2004

Contact

full name

Takahiro Yamazaki

primary email

tay2007@med.cornell.edu

VIVO Weill Cornell Medical College

Takahiro Yamazaki Research Associate in Radiation Oncology

Publications

selected publications

Background

education and training

Contact

full name

primary email